PT-141 10mg (Bremelanotide)

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied in controlled laboratory environments for its interaction with MC3R and MC4R receptor pathways. Derived from melanocortin peptide research, PT-141 has been investigated for its influence on central nervous system signaling mechanisms and receptor-mediated neuroendocrine pathways. Due to its selective melanocortin receptor activity, it remains a compound of interest in peptide-based signaling and neurobiology research models. Preclinical investigations have examined PT-141 for its interaction with cyclic AMP (cAMP) signaling cascades and melanocortin system modulation frameworks. Ongoing scientific studies continue to evaluate its receptor-binding characteristics, intracellular signaling responses, and downstream molecular behavior within strictly controlled experimental research conditions. This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. PT-141 (Bremelanotide) is intended strictly for laboratory research and analytical purposes only and is not for human consumption.